Objective: The objective of this study was to determine whether flow velocities measured on Doppler ultrasound after endovascular aneurysm repair can predict whether a type II endoleak can resolve without intervention. In addition, we assessed the relationship of flow velocities to sac growth and the need for an intervention. We hypothesized that hemodynamic properties suggesting low flow velocity would predict resolution of type II endoleaks.
Objective: The objective of this study was to determine whether flow velocities measured on Doppler ultrasound after endovascular aneurysm repair can predict whether a type II endoleak can resolve without intervention. In addition, we assessed the relationship of flow velocities to sac growth and the need for an intervention. We hypothesized that hemodynamic properties suggesting low flow velocity would predict resolution of type II endoleaks.
Methods: Patients with type II endoleaks after endovascular aneurysm repair identified on Doppler ultrasound between January 2014 and December 2017 were retrospectively analyzed. Twenty patients were found to have type II endoleaks, and they were split into two groups. Group 1 consisted of 10 patients with resolved endoleaks or shrinking sac size; group 2 consisted of 10 patients with increasing sac size or those who required intervention to seal the endoleak because of an increased sac size. An analysis of the velocities of the endoleak nidus was conducted.
Results: Doppler ultrasound velocities were significantly lower in patients with resolved type II endoleaks and in those with shrinking aneurysm sac size compared with those requiring intervention or demonstrating an increase in aneurysm sac size (43.6 6 20.5 cm/s vs 147.30 6 103.45 cm/s; P < .01). Nine of 10 patients in group 2 underwent intervention with either translumbar embolization or transarterial embolization, with only 1 having complete resolution of the type II endoleak despite intervention. All patients in group 2 had at least one duplex ultrasound examination with endoleak nidus velocities >100 cm/s, whereas there was no patient in group 1 who had any duplex ultrasound examination with endoleak nidus velocities >100 cm/s. Average follow-up time was similar in both groups, with group 1 at 581 days and group 2 at 547 days postoperatively.
Conclusions: Doppler ultrasound velocities of type II endoleaks can be used to predict whether type II endoleaks will spontaneously seal or lead to sac growth. Type II endoleaks on Doppler ultrasound with endoleak nidus flow velocities >100 cm/s remain persistent, even with attempted treatment.
Author Disclosures: S. Maximus: Nothing to disclose; C. Skelly: Nothing to disclose; R. Milner: Nothing to disclose. Objective: Endovascular aneurysm repair (EVAR) is associated with greater risk of graft-related complications and need for secondary interventions compared with open repair. Type II endoleak (EL-2) is the most common complication. We examined the hypothesis that a functionally occluded inferior mesenteric artery (IMA) before EVAR is associated with fewer secondary interventions for EL-2.
Role of the Inferior Mesenteric Artery in Predicting Secondary
Methods: All nonruptured abdominal aortic aneurysms (AAAs) treated by EVAR using Food and Drug Administration-approved endografts from January 2005 to December 2014 were retrospectively reviewed, including computed tomography angiograms. Preoperative patency of the IMA and any secondary interventions performed after the index EVAR procedure were recorded. A functionally occluded IMA was defined as one that was chronically occluded or severely stenosed on preoperative imaging or coil embolized before EVAR. Secondary interventions for persistent EL-2 were indicated when AAA sac diameter increased by >5 mm.
Results: The study cohort comprised 402 patients (74 women) with a mean age of 75 6 8 years. The mean preoperative AAA diameter was 5.6 6 1.0 cm. During follow-up, 104 patients (26%) died. Median followup of survivors was 50 months. Prevalence of endoleaks was as follows: type I, 2.1%; type II, 19.3%; type III, 0.9%; type IV, 0.7%; and type V, 0.2%. Patients with a functionally occluded IMA underwent significantly fewer secondary interventions for EL-2 compared with patients with a patent IMA (2.7% vs 8.8%; P ¼ .008). A functionally occluded IMA was associated with fewer vessel-specific interventions compared with a patent IMA (5/100 EVARs vs 13.1/100 EVARs; P ¼ .008). All secondary interventions in the functionally occluded IMA group involved the lumbar arteries.
When the IMA was patent, secondary interventions were equally distributed between the lumbar arteries and IMA. Logistic regression confirmed that a functionally patent IMA was associated with greater number of secondary interventions for EL-2 (odds ratio, 3.4; 95% confidence interval, 1.3-9.0; P ¼ .012).
Conclusions: Patients with a functionally occluded IMA required significantly fewer secondary interventions for EL-2 after EVAR. In addition, the type of vessels intervened on was primarily lumbar arteries. Among patients with a patent IMA, preoperative coil embolization may reduce secondary interventions and improve the long-term durability of EVAR.
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Management of Advanced Aortoiliac
Results: Eighteen patients (36 limbs) were analyzed. Patients had an average age of 63.6 years, with an average American Society of Anesthesiologists score of 3.33. The average length of stay was 5.6 days. Six cases were emergent and done for aortic or iliac occlusion. Successful endovascular recannulization was achieved in 100% of limbs, with 44% requiring concurrent femoral endarterectomy. Thirty-two limbs have been seen in follow-up with an average primary patency of 78% (25/32) and primary assisted patency of 87.5% (28/32) at an average of 4.5 months (range, 1-20 months). Four limbs (4/32 [12.5%]) have required an aortobifemoral bypass, with secondary patency of 100%. Procedure-related complications were seen in three patients (two groin infections and one patient with acute-on-chronic renal failure). Procedure-related mortality was seen in one patient who died of aspiration pneumonia.
Conclusions: The IBE offers an endovascular solution to advanced AIOD, with precannulation of the contralateral gate providing a technical advantage to other endovascular solutions. An endovascular first option with the IBE offers promising primary patency rates and does not preclude future open solutions. Long-term follow-up is needed to document IBE durability in AIOD.
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